Pangenomic Health Inc.
NARA
CNSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 3.70% | -64.57% | |||
| Gross Profit | -3.70% | 64.57% | |||
| SG&A Expenses | 11.05% | 107.65% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.29% | -26.13% | |||
| Operating Income | -8.29% | 26.13% | |||
| Income Before Tax | -2.79% | 53.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.79% | 53.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.79% | 53.78% | |||
| EBIT | -8.29% | 26.13% | |||
| EBITDA | -8.29% | 26.14% | |||
| EPS Basic | 46.63% | 65.63% | |||
| Normalized Basic EPS | 46.47% | 49.37% | |||
| EPS Diluted | 46.63% | 65.63% | |||
| Normalized Diluted EPS | 46.47% | 49.37% | |||
| Average Basic Shares Outstanding | 92.66% | 34.53% | |||
| Average Diluted Shares Outstanding | 92.66% | 34.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||